TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +1.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XLO
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
81.5% 56.7% 91.4% 89.5% 79.0% 84.7% 93.8%
77.9% 53.0% 89.4% 86.5% 73.4% 77.8% 88.9%
77.9% 53.0% 89.4% 86.5% 73.4% 77.8% 88.9%
– – 0.2% 0.2% – – 3.2%
15.7% 37.7% 6.1% 5.2% – – –
38.6% 114.6% 16.3% 24.1% 39.6% 75.2% 77.2%
8.3% 61.0% 5.8% 15.2% 26.2% 38.4% 36.4%
– 8.2% 0.4% 5.5% 7.2% 1.7% 0.9%
4.0% 15.0% 1.4% 2.2% 1.7% 3.6% 2.0%
15.3% 20.4% 4.3% 2.3% – – –
61.4% -14.6% 83.7% 75.9% 60.4% 24.8% 22.8%
-47.6% -234.3% -72.6% -179.0% -534.3% -539.9% -270.7%
0.0% 0.1% 0.2% 19.7% 3.2% 5.4% 54.0%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?